Pfizer Recalls Additional Blood Pressure Medication
Pfizer Recalls Another Blood Pressure Medication
Hypertension tablets may pose long-term cancer risk
360b / Alamy Stock Photo Drugmaker Pfizer issued a on five lots of the prescription blood pressure medication Accupril (Quinapril HCl Tablets) due to the presence of a cancer-causing impurity that was detected to be above the acceptable daily intake level set by the Food and Drug Administration (FDA). Recent testing found elevated levels of a nitrosamine impurity, Nnitroso-quinapril, in the drug’s 10 -, 20 - and 40 -milligram tablets that were distributed nationwide (including Puerto Rico) to wholesalers and distributors between December 2019 and April 2022. To date, the company is not aware of reports of anyone being sickened by the recalled drugs. Join today and save 25% off the standard annual rate. Get instant access to discounts, programs, services, and the information you need to benefit every area of your life. In March, Pfizer for elevated levels of a different type of nitrosamine. Recalled blood pressure medications
Accupril (Quinapril HCl Tablets), 10 mg NDC: 0071-0530-23, lot No. DR9639, expiration date 03/31/2023 Accupril (Quinapril HCl Tablets), 20 mg NDC: 0071-0532-23, lot No. DX8682, expiration date 03/31/2023 NDC: 0071-0532-23, lot No. DG1188, expiration date 03/31/2022 Accupril (Quinapril HCl Tablets), 40 mg NDC: 0071-0535-23, lot No. DX6031, expiration date 03/31/2023 NDC: 0071-0535-23, lot No. CK6260, expiration date 03/31/2022 Advice to patients
Patients who are taking Accupril should speak with their health care provider or pharmacy to determine whether they have the recalled product. Those who have the recalled medication should contact Sedgwick, a claims-management company, toll-free at 888-345-0481, Monday through Friday , from 8 a .m . to 5 p .m . ET for instructions on how to return the recalled tablets and receive reimbursement. Any adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s or by mail or fax using this . What are nitrosamines
Long -term ingestion of Nnitroso-quinapril, a type of nitrosamine, may be associated with a potential increased risk in humans. However, there is no immediate risk to patients taking the recalled medication s, according to Pfizer. Nitrosamine s are present in water and foods such as cured and grilled meats, dairy products and vegetables. Although everyone is exposed to some level of nitrosamines, the FDA set an internationally recognized acceptable daily intake limit for the impurity. The FDA recommends that drugs containing levels above the acceptable daily intake limit be recalled by the manufacturer as appropriate. A person taking a drug that contains nitrosamines at or below the acceptable daily limit every day for 70 years is not expected to have an increased cancer risk, according to the FDA. Aaron Kassraie writes about issues important to military veterans and their families for AARP. He also serves as a general assignment reporter. Kassraie previously covered U.S. foreign policy as a correspondent for the Kuwait News Agency’s Washington bureau and worked in news gathering for USA Today and Al Jazeera English. More on Health
Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures
Close In the next 24 hours, you will receive an email to confirm your subscription to receive emails related to AARP volunteering. Once you confirm that subscription, you will regularly receive communications related to AARP volunteering. In the meantime, please feel free to search for ways to make a difference in your community at Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.